SP

Sagarika Pattanaik

Active Director Director DIN 10513498
DIN 10513498 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sagarika Pattanaik

Data last updated:

Sagarika Pattanaik is a Director at Srusty Pharma Private Limited (since 2024).

DIN 10513498
Primary Designation Director
First Appointment 19 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srusty Pharma Private Limited U46497OD2024PTC045056
Director19 Feb 20242024Active

Board colleagues of Sagarika Pattanaik

Directorship timeline

Open interactive timeline →
Srusty Pharma Private Limited
Premium access

Shareholding and investment profile for Sagarika Pattanaik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagarika Pattanaik

Sagarika Pattanaik currently holds 1 directorship: Srusty Pharma Private Limited (Director, since 19 Feb 2024).

Sagarika Pattanaik was first appointed on 19 Feb 2024 as Director at Srusty Pharma Private Limited.

The current boards of Sagarika Pattanaik's companies include Banalata Pattnaik (Srusty Pharma Private Limited), Sagarika Parida (Srusty Pharma Private Limited), Subhasri Pradhan (Srusty Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available